Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study

Background and AimsThe prognostic value of bile duct invasion (BDI) remains controversial. We aimed to investigate the prognostic value of BDI and the stage of BDI in different staging systems.MethodsPatients with hepatocellular carcinoma (HCC) from nine hepatobiliary medical centers who underwent R...

Full description

Bibliographic Details
Main Authors: Qizhen Huang, Yufeng Chen, Kongying Lin, Chuandong Sun, Shuguo Zheng, Jinhong Chen, Yifan Wang, Yanming Zhou, Weiping Zhou, Jingfeng Liu, Yongyi Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.673285/full
_version_ 1819025003539070976
author Qizhen Huang
Yufeng Chen
Kongying Lin
Chuandong Sun
Shuguo Zheng
Jinhong Chen
Yifan Wang
Yanming Zhou
Weiping Zhou
Jingfeng Liu
Jingfeng Liu
Yongyi Zeng
Yongyi Zeng
author_facet Qizhen Huang
Yufeng Chen
Kongying Lin
Chuandong Sun
Shuguo Zheng
Jinhong Chen
Yifan Wang
Yanming Zhou
Weiping Zhou
Jingfeng Liu
Jingfeng Liu
Yongyi Zeng
Yongyi Zeng
author_sort Qizhen Huang
collection DOAJ
description Background and AimsThe prognostic value of bile duct invasion (BDI) remains controversial. We aimed to investigate the prognostic value of BDI and the stage of BDI in different staging systems.MethodsPatients with hepatocellular carcinoma (HCC) from nine hepatobiliary medical centers who underwent R0 resection were included. Overall survival (OS) was assessed using the Kaplan–Meier method and tested using the log-rank test. The prognostic effect of BDI was analyzed using univariate and multivariate Cox proportional hazard regression analyses. The predictive performance of these models was evaluated using the concordance index and time-dependent receiver operating characteristic curve (tdAUC).ResultsOf 1021 patients with HCC, 177 had BDI. OS was worse in the HCC with BDI group than in the HCC without BDI group (p<0.001); multivariate analysis identified BDI as an independent risk factor for OS. After adjustment for interference of confounding factors using the Cox proportional hazard regression model, HCC with BDI and without macrovascular invasion was classified as Barcelona Clinic Liver Cancer (BCLC) B, eighth edition American Joint Committee on Cancer (AJCC) IIIA, and China Liver Cancer (CNLC) IIb, respectively, whereas HCC with BDI and macrovascular was classified as BCLC C, AJCC IIIB, and CNLC IIIA, respectively. C-indexes and tdAUCs of the adjusted staging systems were superior to those of the corresponding current staging systems.ConclusionWe constructed adjusted staging systems with the BDI status, improved their predictive performance and facilitate clinical use.
first_indexed 2024-12-21T05:03:46Z
format Article
id doaj.art-2041dfa5aa1d435db3e622046b01f3ac
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-21T05:03:46Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-2041dfa5aa1d435db3e622046b01f3ac2022-12-21T19:15:10ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-10-011110.3389/fonc.2021.673285673285Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter StudyQizhen Huang0Yufeng Chen1Kongying Lin2Chuandong Sun3Shuguo Zheng4Jinhong Chen5Yifan Wang6Yanming Zhou7Weiping Zhou8Jingfeng Liu9Jingfeng Liu10Yongyi Zeng11Yongyi Zeng12Department of Radiation Oncology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Hepatopancreatobiliary Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, ChinaDepartment of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qingdao University, Qingdao, ChinaInstitute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, ChinaDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Hepato-Biliary-Pancreato-Vascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, ChinaThe Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, ChinaDepartment of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China0Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China0Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaBackground and AimsThe prognostic value of bile duct invasion (BDI) remains controversial. We aimed to investigate the prognostic value of BDI and the stage of BDI in different staging systems.MethodsPatients with hepatocellular carcinoma (HCC) from nine hepatobiliary medical centers who underwent R0 resection were included. Overall survival (OS) was assessed using the Kaplan–Meier method and tested using the log-rank test. The prognostic effect of BDI was analyzed using univariate and multivariate Cox proportional hazard regression analyses. The predictive performance of these models was evaluated using the concordance index and time-dependent receiver operating characteristic curve (tdAUC).ResultsOf 1021 patients with HCC, 177 had BDI. OS was worse in the HCC with BDI group than in the HCC without BDI group (p<0.001); multivariate analysis identified BDI as an independent risk factor for OS. After adjustment for interference of confounding factors using the Cox proportional hazard regression model, HCC with BDI and without macrovascular invasion was classified as Barcelona Clinic Liver Cancer (BCLC) B, eighth edition American Joint Committee on Cancer (AJCC) IIIA, and China Liver Cancer (CNLC) IIb, respectively, whereas HCC with BDI and macrovascular was classified as BCLC C, AJCC IIIB, and CNLC IIIA, respectively. C-indexes and tdAUCs of the adjusted staging systems were superior to those of the corresponding current staging systems.ConclusionWe constructed adjusted staging systems with the BDI status, improved their predictive performance and facilitate clinical use.https://www.frontiersin.org/articles/10.3389/fonc.2021.673285/fullhepatocellular carcinomabile duct invasionstaging systemsurvivalprognosis
spellingShingle Qizhen Huang
Yufeng Chen
Kongying Lin
Chuandong Sun
Shuguo Zheng
Jinhong Chen
Yifan Wang
Yanming Zhou
Weiping Zhou
Jingfeng Liu
Jingfeng Liu
Yongyi Zeng
Yongyi Zeng
Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study
Frontiers in Oncology
hepatocellular carcinoma
bile duct invasion
staging system
survival
prognosis
title Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study
title_full Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study
title_fullStr Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study
title_full_unstemmed Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study
title_short Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study
title_sort redefining hepatocellular carcinoma staging systems based on the bile duct invasion status a multicenter study
topic hepatocellular carcinoma
bile duct invasion
staging system
survival
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2021.673285/full
work_keys_str_mv AT qizhenhuang redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT yufengchen redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT kongyinglin redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT chuandongsun redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT shuguozheng redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT jinhongchen redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT yifanwang redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT yanmingzhou redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT weipingzhou redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT jingfengliu redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT jingfengliu redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT yongyizeng redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy
AT yongyizeng redefininghepatocellularcarcinomastagingsystemsbasedonthebileductinvasionstatusamulticenterstudy